| Product Code: ETC10797294 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pharmacogenomics Technology Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 Ireland Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 Ireland Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Ireland Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 Ireland Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Ireland Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
3.9.1 Increasing demand for personalized medicine |
3.9.2 Advancements in genomic research and technology |
3.9.3 Government initiatives and funding to promote precision medicine |
4 Ireland Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenomics technology |
4.3.2 Limited awareness and adoption of pharmacogenomic testing |
4.3.3 Regulatory hurdles and data privacy concerns |
5 Ireland Pharmacogenomics Technology Market Trends |
6 Ireland Pharmacogenomics Technology Market, By Types |
6.1 Ireland Pharmacogenomics Technology Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Genotyping, 2021 - 2031F |
6.1.4 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.1.5 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Gene Expression Profiling, 2021 - 2031F |
6.1.6 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Bioinformatics Solutions, 2021 - 2031F |
6.1.7 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Companion Diagnostics, 2021 - 2031F |
6.2 Ireland Pharmacogenomics Technology Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.3 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Drug Response Analysis, 2021 - 2031F |
6.2.4 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Oncology Treatment, 2021 - 2031F |
6.2.5 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031F |
6.2.6 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.3 Ireland Pharmacogenomics Technology Market, By Testing Method |
6.3.1 Overview and Analysis |
6.3.2 Ireland Pharmacogenomics Technology Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.3.3 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Microarray, 2021 - 2031F |
6.3.4 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031F |
6.3.5 Ireland Pharmacogenomics Technology Market Revenues & Volume, By AI-Based Analytics, 2021 - 2031F |
6.3.6 Ireland Pharmacogenomics Technology Market Revenues & Volume, By DNA Microarray, 2021 - 2031F |
6.4 Ireland Pharmacogenomics Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Pharma Companies, 2021 - 2031F |
6.4.3 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.4 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.4.5 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Academic Institutions, 2021 - 2031F |
6.4.6 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 Ireland Pharmacogenomics Technology Market, By Market Driver |
6.5.1 Overview and Analysis |
6.5.2 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Advancements in Precision Medicine, 2021 - 2031F |
6.5.3 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Increase in Genetic Testing, 2021 - 2031F |
6.5.4 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Growing Interest in Targeted Therapy, 2021 - 2031F |
6.5.5 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Expansion in Pharmacovigilance, 2021 - 2031F |
6.5.6 Ireland Pharmacogenomics Technology Market Revenues & Volume, By Demand for Tailored Therapeutics, 2021 - 2031F |
7 Ireland Pharmacogenomics Technology Market Import-Export Trade Statistics |
7.1 Ireland Pharmacogenomics Technology Market Export to Major Countries |
7.2 Ireland Pharmacogenomics Technology Market Imports from Major Countries |
8 Ireland Pharmacogenomics Technology Market Key Performance Indicators |
8.1 Number of research collaborations and partnerships in pharmacogenomics |
8.2 Rate of adoption of pharmacogenomic testing in healthcare institutions |
8.3 Number of pharmacogenomic tests approved by regulatory authorities |
9 Ireland Pharmacogenomics Technology Market - Opportunity Assessment |
9.1 Ireland Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Ireland Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
9.4 Ireland Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Ireland Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
10 Ireland Pharmacogenomics Technology Market - Competitive Landscape |
10.1 Ireland Pharmacogenomics Technology Market Revenue Share, By Companies, 2024 |
10.2 Ireland Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here